[
  {
    "ts": null,
    "headline": "HEICO Likely to Sustain Revenue Growth Into Fiscal 2026, Truist Says",
    "summary": "HEICO (HEI) is expected to sustain revenue growth of high-single digit to low-double digit into fisc",
    "url": "https://finnhub.io/api/news?id=f9605fb65da764f7739eef91b331a18f599efa864017efeb4f5086872ee9e184",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756237832,
      "headline": "HEICO Likely to Sustain Revenue Growth Into Fiscal 2026, Truist Says",
      "id": 136536795,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "HEICO (HEI) is expected to sustain revenue growth of high-single digit to low-double digit into fisc",
      "url": "https://finnhub.io/api/news?id=f9605fb65da764f7739eef91b331a18f599efa864017efeb4f5086872ee9e184"
    }
  },
  {
    "ts": null,
    "headline": "Truist Financial Corp. stock outperforms competitors on strong trading day",
    "summary": "Truist Financial Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=769753a4ec930d0f07f9aa1a81be18bcd6dbfd9118fe8e4d0589f62de03ec58c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756226820,
      "headline": "Truist Financial Corp. stock outperforms competitors on strong trading day",
      "id": 136547553,
      "image": "",
      "related": "TFC",
      "source": "MarketWatch",
      "summary": "Truist Financial Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=769753a4ec930d0f07f9aa1a81be18bcd6dbfd9118fe8e4d0589f62de03ec58c"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly's Investigational Obesity Drug Presents Major Revenue Opportunity, Truist Says",
    "summary": "Eli Lilly's (LLY) investigational oral drug orforglipron met its primary endpoint in a phase 3 trial",
    "url": "https://finnhub.io/api/news?id=efc018a15b4cfb12d0ee0a6230c6b1673f11b70cbacd1f1d572aea6eff6feb09",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756220741,
      "headline": "Eli Lilly's Investigational Obesity Drug Presents Major Revenue Opportunity, Truist Says",
      "id": 136530073,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Eli Lilly's (LLY) investigational oral drug orforglipron met its primary endpoint in a phase 3 trial",
      "url": "https://finnhub.io/api/news?id=efc018a15b4cfb12d0ee0a6230c6b1673f11b70cbacd1f1d572aea6eff6feb09"
    }
  },
  {
    "ts": null,
    "headline": "AMD Stock Upgraded To Buy. What Caused The Change In Sentiment?",
    "summary": "AMD stock earned a fresh buy rating after a Wall Street analyst spoke with industry contacts about adoption of the company’s AI chips.",
    "url": "https://finnhub.io/api/news?id=486defdecb371121df69310d46e1a01cf567ca63721eef3d5bfb0a6d21a05628",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756216927,
      "headline": "AMD Stock Upgraded To Buy. What Caused The Change In Sentiment?",
      "id": 136525461,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "AMD stock earned a fresh buy rating after a Wall Street analyst spoke with industry contacts about adoption of the company’s AI chips.",
      "url": "https://finnhub.io/api/news?id=486defdecb371121df69310d46e1a01cf567ca63721eef3d5bfb0a6d21a05628"
    }
  },
  {
    "ts": null,
    "headline": "FNB Hires Alfred D. Cho as Chief Consumer Banking Officer",
    "summary": "First National Bank, the largest subsidiary of F.N.B. Corporation (NYSE: FNB), announced today that it has hired Alfred D. Cho as Chief Consumer Banking Officer, succeeding Barry Robinson upon his retirement.",
    "url": "https://finnhub.io/api/news?id=848f7d5491e8eb19388a622a2649cc949286ada98801d3cfa0b3c5723819881f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756216800,
      "headline": "FNB Hires Alfred D. Cho as Chief Consumer Banking Officer",
      "id": 136525954,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "First National Bank, the largest subsidiary of F.N.B. Corporation (NYSE: FNB), announced today that it has hired Alfred D. Cho as Chief Consumer Banking Officer, succeeding Barry Robinson upon his retirement.",
      "url": "https://finnhub.io/api/news?id=848f7d5491e8eb19388a622a2649cc949286ada98801d3cfa0b3c5723819881f"
    }
  },
  {
    "ts": null,
    "headline": "Update: Truist Securities Upgrades Advanced Micro Devices to Buy From Hold, Raises Price Target to $213 From $173",
    "summary": "(Updated to include Truist's commentary) Truist Securities upgraded Advanced Micro Devices (AMD)",
    "url": "https://finnhub.io/api/news?id=d966e8d1053d940f798e688700e47bbffbfa27dbbd2cd46ec84079c3e4441f8b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756213992,
      "headline": "Update: Truist Securities Upgrades Advanced Micro Devices to Buy From Hold, Raises Price Target to $213 From $173",
      "id": 136525478,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "(Updated to include Truist's commentary) Truist Securities upgraded Advanced Micro Devices (AMD)",
      "url": "https://finnhub.io/api/news?id=d966e8d1053d940f798e688700e47bbffbfa27dbbd2cd46ec84079c3e4441f8b"
    }
  },
  {
    "ts": null,
    "headline": "Is AMD a Top Quantum Computing Stock to Buy Now?",
    "summary": "Advanced Micro Devices stock has more than doubled from its April lows, and just partnered with IBM on quantum computing.",
    "url": "https://finnhub.io/api/news?id=a376e00642117692e3f7711b5e2a33f489111ff1978b9bfae0f9fa4c94e3de6a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756212555,
      "headline": "Is AMD a Top Quantum Computing Stock to Buy Now?",
      "id": 136530139,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Advanced Micro Devices stock has more than doubled from its April lows, and just partnered with IBM on quantum computing.",
      "url": "https://finnhub.io/api/news?id=a376e00642117692e3f7711b5e2a33f489111ff1978b9bfae0f9fa4c94e3de6a"
    }
  },
  {
    "ts": null,
    "headline": "Truist upgrades AMD to Buy, sees AI traction driving stock higher",
    "summary": "Investing.com -- Advanced Micro Devices shares are up over 2% premarket on Tuesday after Truist analysts upgraded the stock to Buy from Hold and lifted their price target to $213 from $173 per share.",
    "url": "https://finnhub.io/api/news?id=910b98673f18cc767a5d8f63835e0050abc60a67acd7cb74c57177cbb8e712c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756206566,
      "headline": "Truist upgrades AMD to Buy, sees AI traction driving stock higher",
      "id": 136523753,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Investing.com -- Advanced Micro Devices shares are up over 2% premarket on Tuesday after Truist analysts upgraded the stock to Buy from Hold and lifted their price target to $213 from $173 per share.",
      "url": "https://finnhub.io/api/news?id=910b98673f18cc767a5d8f63835e0050abc60a67acd7cb74c57177cbb8e712c3"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons TFC is Risky and 1 Stock to Buy Instead",
    "summary": "Truist Financial has been treading water for the past six months, recording a small return of 1.1% while holding steady at $45.84. The stock also fell short of the S&P 500’s 8.1% gain during that period.",
    "url": "https://finnhub.io/api/news?id=8fafc3ff43d4e26cc3be2f3cd47fb9f09df743d53ce0814d65e573236fc6dda9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756180847,
      "headline": "3 Reasons TFC is Risky and 1 Stock to Buy Instead",
      "id": 136525956,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Truist Financial has been treading water for the past six months, recording a small return of 1.1% while holding steady at $45.84. The stock also fell short of the S&P 500’s 8.1% gain during that period.",
      "url": "https://finnhub.io/api/news?id=8fafc3ff43d4e26cc3be2f3cd47fb9f09df743d53ce0814d65e573236fc6dda9"
    }
  },
  {
    "ts": null,
    "headline": "Truist Financial Reiterates a Buy Rating on AbCellera Biologics (ABCL), Sets a $10 PT",
    "summary": "AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the top strong buy stocks under $5 to buy now. In a report released on August 14, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ:ABCL), setting a price target of $10.00. AbCellera Biologics Inc. (NASDAQ:ABCL) reported its fiscal Q2 results on August […]",
    "url": "https://finnhub.io/api/news?id=eab98a96326a2e19b18b2fcee4f81436ed321f232735173fd456df30721fc473",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756180586,
      "headline": "Truist Financial Reiterates a Buy Rating on AbCellera Biologics (ABCL), Sets a $10 PT",
      "id": 136524124,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the top strong buy stocks under $5 to buy now. In a report released on August 14, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ:ABCL), setting a price target of $10.00. AbCellera Biologics Inc. (NASDAQ:ABCL) reported its fiscal Q2 results on August […]",
      "url": "https://finnhub.io/api/news?id=eab98a96326a2e19b18b2fcee4f81436ed321f232735173fd456df30721fc473"
    }
  }
]